Lupus nephritis: Current update

Ramesh Saxena; Tina Mahajan; Chandra Mohan

doi:10.1186/ar3378

Lupus nephritis: Current update

Ramesh Saxena, Tina Mahajan, Chandra Mohan

Research output: Contribution to journal › Review article

81 Scopus citations

Abstract

Lupus nephritis is a major cause of morbidity and mortality in patients with systemic lupus erythematosus. The general consensus is that 60% of lupus patients will develop clinically relevant nephritis at some time in the course of their illness. Prompt recognition and treatment of renal disease is important, as early response to therapy is correlated with better outcome. The present review summarizes our current understanding of the pathogenic mechanisms underlying lupus nephritis and how the disease is currently diagnosed and treated.

Original language	English (US)
Article number	240
Journal	Arthritis Research and Therapy
Volume	13
Issue number	5
DOIs	https://doi.org/10.1186/ar3378
State	Published - Sep 28 2011

ASJC Scopus subject areas

Rheumatology
Immunology and Allergy
Immunology

Access to Document

10.1186/ar3378

Fingerprint Dive into the research topics of 'Lupus nephritis: Current update'. Together they form a unique fingerprint.

Cite this

Saxena, R., Mahajan, T., & Mohan, C. (2011). Lupus nephritis: Current update. Arthritis Research and Therapy, 13(5), [240]. https://doi.org/10.1186/ar3378

@article{14b39ffee457426aac40e828625fe7a0,

title = "Lupus nephritis: Current update",

abstract = "Lupus nephritis is a major cause of morbidity and mortality in patients with systemic lupus erythematosus. The general consensus is that 60% of lupus patients will develop clinically relevant nephritis at some time in the course of their illness. Prompt recognition and treatment of renal disease is important, as early response to therapy is correlated with better outcome. The present review summarizes our current understanding of the pathogenic mechanisms underlying lupus nephritis and how the disease is currently diagnosed and treated.",

author = "Ramesh Saxena and Tina Mahajan and Chandra Mohan",

year = "2011",

month = sep,

day = "28",

doi = "10.1186/ar3378",

language = "English (US)",

volume = "13",

journal = "Arthritis Research and Therapy",

issn = "1478-6354",

publisher = "BioMed Central",

number = "5",

}

TY - JOUR

T1 - Lupus nephritis

T2 - Current update

AU - Saxena, Ramesh

AU - Mahajan, Tina

AU - Mohan, Chandra

PY - 2011/9/28

Y1 - 2011/9/28

N2 - Lupus nephritis is a major cause of morbidity and mortality in patients with systemic lupus erythematosus. The general consensus is that 60% of lupus patients will develop clinically relevant nephritis at some time in the course of their illness. Prompt recognition and treatment of renal disease is important, as early response to therapy is correlated with better outcome. The present review summarizes our current understanding of the pathogenic mechanisms underlying lupus nephritis and how the disease is currently diagnosed and treated.

AB - Lupus nephritis is a major cause of morbidity and mortality in patients with systemic lupus erythematosus. The general consensus is that 60% of lupus patients will develop clinically relevant nephritis at some time in the course of their illness. Prompt recognition and treatment of renal disease is important, as early response to therapy is correlated with better outcome. The present review summarizes our current understanding of the pathogenic mechanisms underlying lupus nephritis and how the disease is currently diagnosed and treated.

UR - http://www.scopus.com/inward/record.url?scp=81255196460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255196460&partnerID=8YFLogxK

U2 - 10.1186/ar3378

DO - 10.1186/ar3378

M3 - Review article

C2 - 22078716

AN - SCOPUS:81255196460

VL - 13

JO - Arthritis Research and Therapy

JF - Arthritis Research and Therapy

SN - 1478-6354

IS - 5

M1 - 240

ER -